Page last updated: 2024-08-23

mifepristone and Liver Dysfunction

mifepristone has been researched along with Liver Dysfunction in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Groen, AK; Hoekstra, M; Ouweneel, AB; van der Geest, R; van der Sluis, RJ; Van Eck, M1
Appleyard, C; Le, T; Swain, MG; Wallace, J; Wong, H1

Other Studies

2 other study(ies) available for mifepristone and Liver Dysfunction

ArticleYear
Endogenous glucocorticoids exacerbate cholestasis-associated liver injury and hypercholesterolemia in mice.
    Toxicology and applied pharmacology, 2016, 09-01, Volume: 306

    Topics: 1-Naphthylisothiocyanate; Adrenalectomy; Animals; Bile Acids and Salts; Cholestasis; Cholesterol; Corticosterone; Hypercholesterolemia; Liver; Liver Diseases; Mice, Inbred C57BL; Mifepristone; Receptors, Cytoplasmic and Nuclear; Receptors, Glucocorticoid

2016
Endogenous glucocorticoids released during acute toxic liver injury enhance hepatic IL-10 synthesis and release.
    The American journal of physiology, 1999, Volume: 276, Issue:1

    Topics: Acute Disease; Adrenalectomy; Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Corticosterone; Glucocorticoids; Hormone Antagonists; Interleukin-10; Liver; Liver Diseases; Male; Mifepristone; Rats; Rats, Sprague-Dawley; RNA, Messenger; Survival Analysis; Tumor Necrosis Factor-alpha

1999